Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EMP3 |
| Upstream (Parents) |
|---|
| (<<) RAB31 → EMP3 |
| (<<) BASP1 → EMP3 |
| (<<) LAPTM5 → EMP3 |
| (<<) FCER1G → EMP3 |
| Downstream (Children) |
|---|
| EMP3 → ACHE (>>) |
| EMP3 → STK32B (>>) |
| EMP3 → CD84 (>>) |
| EMP3 → ALK (>>) |
| EMP3 → HPGDS (>>) |
| EMP3 → NGF (>>) |
| EMP3 → FZD5 (>>) |
| EMP3 → KIFC3 (>>) |
| EMP3 → KIR2DS1 (>>) |
| EMP3 → ITGAX (>>) |
| EMP3 → BASP1 (>>) |
| EMP3 → DAB2 (>>) |
| EMP3 → HMGB3L1 (>>) |
